No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
129 |
4. Check minimum number of eventsNone |
129 |
5. Include endpointsNone |
129 |
6. Filter based on genotype QC (FinnGen only) |
129 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other or unspecified immunodeficiency
based on the number of shared cases.
Similar with more cases:
- Other immunodeficiencies
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 792 | 445 | 340 |
| Only index persons | 679 | 396 | 283 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 41.63 | 44.77 | 37.09 |
| Only index persons | 41.98 | 44.85 | 37.96 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 129 | 80 | 49 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 45.28 | 45.49 | 44.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 113
- Matched controls
- 1128
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
105.2
84
*
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
36.4
33
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
25.7
22.9
32
17
J01MA12
ATC
levofloxacin; systemic
8.0
19.2
50
101
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.3
18.2
81
323
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
18.2
17
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
18.2
17
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
18.5
16.3
25
17
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
16.0
15
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
16.0
15
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
9.7
15.5
33
46
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.9
15.1
34
52
J45.9
ICD-10 Finland
Asthma, unspecified
6.3
15.1
46
110
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
14.9
14
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.1
14.7
26
25
TDM10
NOMESCO Finland
Puncture of maxillary antrum
13.1
14.7
26
25
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
28.1
14.3
19
8
J01MA14
ATC
moxifloxacin; systemic
8.7
13.8
31
47
J47
ICD-10 Finland
Bronchiectasis
78.9
12.9
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.4
12.8
24
26
6BA02
NOMESCO Finland
NA
145.2
12.7
13
*
J45.1
ICD-10 Finland
Nonallergic asthma
8.3
12.6
29
45
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.0
12.4
47
140
R03AK06
ATC
salmeterol and fluticasone; inhalant
6.0
12.0
36
81
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.0
11.9
44
127
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.4
11.8
55
200
H02AB07
ATC
prednisone; oral
5.6
11.6
37
90
R03DC03
ATC
montelukast; oral
5.0
11.5
42
119
R03AC02
ATC
salbutamol; inhalant
4.3
11.4
86
477
Z2221
NOMESCO Finland
Medical doctor
4.1
11.2
58
229
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
11.2
47
153
WW200
NOMESCO Finland
Immunization
15.0
11.1
18
14
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
11.9
11.0
20
20
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
8.7
10.7
23
32
TGC00
NOMESCO Finland
Bronchial lavation
21.3
10.6
15
8
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
10.6
10
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.8
10.5
20
22
R03BA05
ATC
fluticasone; inhalant
4.6
10.5
41
123
J01FF01
ATC
clindamycin; systemic
4.1
10.5
51
187
H02AB06
ATC
prednisolone; systemic
3.8
10.4
73
363
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.7
10.3
24
38
J01MA02
ATC
ciprofloxacin; systemic
3.8
10.2
60
260
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
108.6
9.6
10
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
9.5
9
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
10.5
9.4
18
20
R4110
NOMESCO Finland
Physiotherapy
3.9
9.4
48
181
Z3226
NOMESCO Finland
Physiotherapist
4.2
9.4
40
129
ZXE00
NOMESCO Finland
One hour or less
3.5
9.2
67
333
R03AC12
ATC
salmeterol; inhalant
14.2
9.2
15
12
C01CA24
ATC
epinephrine; parenteral
6.8
9.1
23
41
Z3231
NOMESCO Finland
Registered nurse
3.7
8.9
51
207
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.1
8.7
21
35
H02AB04
ATC
methylprednisolone; systemic
4.7
8.6
31
84
XG410
NOMESCO Finland
Flow-volume spirometry
12.1
8.6
15
14
R03BB04
ATC
tiotropium bromide; inhalant
6.9
8.5
21
36
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
+∞
8.4
8
*
ZX120
NOMESCO Finland
Intravenous
5.1
8.3
27
65
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.3
8.2
77
446
Z01.8
ICD-10 Finland
Other specified special examinations
3.7
8.1
41
150
R03AK07
ATC
formoterol and budesonide; inhalant
3.7
7.8
40
147
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.4
7.5
43
172
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
85.3
7.5
8
*
UJF30
NOMESCO Finland
Ileoscopy through colon
5.1
7.5
24
57
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.3
7.5
16
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
7.4
21
43
A07AA02
ATC
nystatin; oral
6.9
7.4
18
30
ZXE20
NOMESCO Finland
More than three and less than five hours
4.1
7.4
31
96
J01DA06
ATC
[U] cefuroxime; systemic
4.2
7.3
29
86
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
7.3
24
59
J01FA06
ATC
roxithromycin; oral
3.0
7.2
60
309
R06.0
ICD-10 Finland
Dyspnoea
3.4
7.2
39
150
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
7.1
22
50
ZXD10
NOMESCO Finland
Scheduled procedure
3.0
7.1
60
312
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.7
7.1
20
41
ZXA05
NOMESCO Finland
Left side
3.3
6.9
40
161
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.6
6.7
19
39
R01AD09
ATC
mometasone; nasal
2.8
6.7
64
356
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
6.7
47
216
Z31.5
ICD-10 Finland
Genetic counselling
5.5
6.6
19
40
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.8
6.5
70
414
R03DA04
ATC
theophylline; systemic, rectal
9.0
6.5
13
16
XQ800
NOMESCO Finland
Prick test
4.3
6.5
24
66
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
73.7
6.5
7
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
6.3
30
103
J31.0
ICD-10 Finland
Chronic rhinitis
4.9
6.3
20
47
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
28.4
6.3
8
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
6.3
6
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
6.3
6
*
D02AE01
ATC
carbamide; topical
5.4
6.2
18
38
A01AB04
ATC
amphotericin B; local oral
9.4
6.2
12
14
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.0
6.1
16
30
E0000UV
ATC
NA
2.7
6.1
58
313
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028026) IgM [Mass/volume] in Serum or Plasma
69
78
17.87
61.94
4.6
2.0
g/l
1.2
1.6
0.40
64
73
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
45
9
75.74
40.87
2.9
1.3
—
—
—
0
0
(4062490)
27
12
28.19
37.72
1.9
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
32
7
60.10
28.02
4.0
1.3
u/ml
509.1
898.9
—
32
7
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
25
13.39
26.00
5.1
2.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
31
40
9.89
23.63
3.4
1.6
g/l
0.2
0.2
0.20
31
40
(42870588) Differential panel, method unspecified - Blood
95
379
6.72
23.10
16.4
6.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
66
7.18
20.17
2.9
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
75
267
5.32
20.15
4.6
1.5
g/l
1.8
2.3
2.45
66
166
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
52
140
5.55
19.41
3.2
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
17
12.93
18.42
2.0
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
52
146
5.29
18.36
4.6
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
99
5.81
18.07
2.8
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
41
99
5.61
17.10
2.4
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
63
224
4.54
16.24
9.0
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
72
295
4.26
15.05
12.1
8.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
87
5.35
14.84
2.8
3.0
e9/l
82.2
71.6
0.75
24
68
(3023419) Bacteria identified in Sputum by Culture
20
9
25.95
14.75
6.1
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
43
122
4.79
14.63
3.1
1.3
—
—
—
0
0
(3000492) Spirometry study
37
96
5.00
13.98
3.2
1.5
—
—
—
0
0
(44790047)
14
12
12.97
13.76
3.0
1.7
—
—
—
0
0
(44790048)
14
12
12.97
13.76
3.0
1.7
—
—
—
0
0
(44806118)
14
12
12.97
13.76
3.0
1.7
—
—
—
0
0
(44790049)
14
12
12.97
13.76
3.0
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
44
6.47
13.15
2.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
40
122
4.30
12.20
3.3
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
45
151
4.04
12.03
2.5
1.5
titre
220.0
537.3
—
6
37
(3003396) Base excess in Arterial blood by calculation
30
74
4.98
11.91
6.6
7.1
mmol/l
1.8
1.6
0.16
22
58
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
24
8.01
11.72
3.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
83
429
3.62
11.33
4.3
2.6
nmol/l
75.7
78.1
0.34
78
380
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
25
7.68
11.31
3.6
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
7
24.00
10.97
2.7
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
0
+∞
10.56
2.1
0.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
10
11.93
10.30
9.5
3.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
72
360
3.26
10.00
6.6
3.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
9
0
+∞
9.49
2.3
0.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
20
7.73
9.49
1.6
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
20
7.73
9.49
2.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
65
316
3.13
9.31
6.2
3.3
e6/l
16.4
42.0
1.14
51
242
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
38
134
3.60
9.21
4.5
2.4
%
21.0
23.0
0.36
31
115
(36304419) Bacteria [Presence] in Urine
61
288
3.12
9.16
4.7
3.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
12
9.93
9.11
3.4
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
87
504
3.23
9.08
22.3
9.0
e9/l
0.0
0.0
0.50
80
411
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
166
3.39
9.04
4.4
3.2
e6/l
1.2
2.2
0.74
27
90
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
71
368
3.07
9.01
7.0
3.2
u/l
31.1
31.5
0.04
71
346
(4010399)
27
76
4.23
8.97
2.2
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
36
5.65
8.91
8.2
8.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
71
372
3.02
8.77
7.4
4.0
e6/l
11.1
39.3
1.50
53
257
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
33
5.78
8.67
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
16
8.17
8.56
1.9
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
17
7.68
8.14
2.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
14
8.50
8.11
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
14
8.50
8.11
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
14
8.50
8.11
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
245
2.97
8.08
2.1
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
20
49
4.65
7.87
2.8
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
59
293
2.87
7.84
5.1
3.2
e6/l
0.1
0.3
0.81
47
218
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
18
41
4.94
7.70
3.4
1.2
u/l
42.1
42.0
0.01
18
34
(3036481) Cortisol [Moles/volume] in Serum or Plasma
30
103
3.49
7.46
2.9
2.4
nmol/l
357.4
376.2
0.20
30
94
(3010503) CD19 cells [#/volume] in Blood
10
5
21.49
7.25
3.2
1.4
e9/l
0.4
0.2
—
10
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
31
5.34
7.13
1.4
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
20
6.51
7.04
1.1
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
20
6.51
7.04
1.1
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
79
3.68
7.01
8.2
4.1
%
0.5
1.2
—
10
28
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
28
5.49
6.88
2.1
1.4
iu/ml
1.7
0.0
—
6
5
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
178
2.91
6.85
4.0
3.0
e6/l
1.3
0.8
0.26
25
100
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
79
479
2.68
6.82
16.3
7.0
mmol/l
1.2
1.2
1.27
73
413
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
14
7.66
6.80
2.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
43
4.40
6.40
3.5
3.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
54
282
2.57
6.21
9.2
4.1
ph
7.4
7.4
—
9
47
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
54
3.95
6.15
2.0
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
22
71
3.53
5.95
8.6
4.1
%
0.0
0.0
—
8
19
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
32
4.79
5.93
1.1
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
24
5.41
5.87
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
22
72
3.48
5.82
7.4
3.9
%
0.3
0.5
—
7
17
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
64
371
2.44
5.79
2.3
1.8
pmol/l
91.4
101.6
0.98
40
174
(3022145) Colonoscopy Study observation
28
107
3.07
5.78
1.5
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
179
2.69
5.77
4.3
3.0
ng/l
1052.9
236.6
0.52
22
122
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
47
237
2.55
5.74
4.7
3.3
ng/l
1882.3
896.3
0.94
41
192
(3021901) Oxygen saturation in Capillary blood
10
17
6.29
5.72
5.1
5.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
22
73
3.43
5.70
8.5
4.1
%
0.0
0.3
—
9
23
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
7
13.69
5.67
1.2
1.4
ug/l
6.0
7.9
—
9
7
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
48
3.93
5.54
2.1
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
0
+∞
5.24
2.2
0.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
6
14.09
5.15
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
45
233
2.43
5.11
9.6
5.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
9
10.64
5.11
2.9
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
61
363
2.29
5.02
14.8
7.3
inr
1.1
1.2
1.01
15
106
(3015235) Bicarbonate [Moles/volume] in Capillary blood
12
30
4.31
4.55
5.8
4.5
mmol/l
26.1
23.9
0.69
12
23
(40768804) Tissue Pathology biopsy report
66
420
2.17
4.48
3.1
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
9
9.38
4.34
2.9
4.8
umol/l
27.8
25.8
—
8
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
13
7.35
4.24
2.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
19
69
3.06
4.24
1.5
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
23
4.63
4.17
1.1
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
23
4.63
4.17
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
7
10.48
4.06
7.1
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
124
1093
4.47
3.99
45.7
12.1
mg/l
21.5
20.9
0.09
107
829
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
90
2.74
3.97
1.7
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
11
7.67
3.92
4.8
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
38
203
2.24
3.90
2.1
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
15
6.36
3.89
1.2
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
15
6.36
3.89
2.1
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
39
3.59
3.87
2.4
6.0
g/l
0.5
0.3
—
7
19
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
8
9.16
3.82
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
146
2.37
3.81
2.2
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
16
5.96
3.73
3.6
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
35
3.68
3.72
1.3
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
96
737
2.18
3.68
9.2
4.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
26
4.09
3.59
1.9
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
249
2.09
3.57
2.7
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
48
290
2.04
3.56
4.0
2.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
13
6.48
3.56
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
13
6.48
3.56
2.0
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
13
6.48
3.56
2.5
1.2
—
—
—
0
0
(3012544) pH of Venous blood
23
102
2.53
3.54
6.3
6.0
—
—
—
0
0
(3044889) 12 lead EKG panel
92
700
2.10
3.54
5.6
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
74
523
1.97
3.49
5.1
3.6
estimate
0.0
0.0
0.00
13
101
(3044640) Blood type and Crossmatch panel - Blood
53
334
2.00
3.48
2.8
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
18
5.29
3.44
5.0
2.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
14
6.01
3.39
2.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
42
247
2.04
3.32
3.4
3.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
71
502
1.92
3.27
5.7
4.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
33
3.55
3.27
1.5
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
28
3.79
3.26
2.2
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
28
3.79
3.26
2.2
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
15
5.61
3.24
4.9
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
11
6.65
3.23
2.3
1.8
pg
33.7
33.4
—
7
11
(3021601) Nitrite [Presence] in Urine by Test strip
73
525
1.90
3.16
7.6
5.0
estimate
0.0
0.0
0.00
12
103
(3009542) Hematocrit [Volume Fraction] of Blood
119
1025
3.08
3.15
38.9
13.7
%
38.7
40.2
1.44
101
816
(3044941) Cell count panel - Synovial fluid
6
8
7.79
3.09
1.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
8
7.79
3.09
3.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
5
10.33
3.00
1.0
1.0
g/l
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
99
797
2.04
2.96
4.9
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
102
830
2.09
2.96
4.7
4.0
pmol/l
14.7
14.6
0.03
97
760
(3009261) Glucose [Presence] in Urine by Test strip
73
535
1.84
2.88
5.2
3.6
estimate
0.0
0.0
0.00
13
97
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
31
3.41
2.84
1.6
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
79
2.49
2.83
9.6
9.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
37
3.16
2.76
1.7
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
19
4.41
2.72
1.4
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
19
4.41
2.72
1.4
1.1
—
—
—
0
0
(4306422)
8
19
4.41
2.72
1.3
1.1
—
—
—
0
0
(4035726)
20
94
2.33
2.72
1.5
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
111
944
2.26
2.69
48.5
15.4
%
14.0
13.6
1.17
111
933
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
20
4.19
2.61
5.4
2.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
20
4.19
2.61
2.8
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
11
5.66
2.57
2.2
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
6
11
5.66
2.57
1.2
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
7
7.37
2.57
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
45
293
1.82
2.55
5.2
3.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
12
5.18
2.43
1.7
1.7
umol/l
42.4
19.2
—
6
12
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
17
4.29
2.39
4.3
3.4
%
60.0
57.5
—
7
17
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
17
4.29
2.39
3.9
3.2
e9/l
4.6
4.6
—
7
17
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
8
6.44
2.39
2.6
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
43
282
1.79
2.35
4.1
3.6
mmol/l
7.3
8.2
0.51
38
243
(3020564) Creatinine [Moles/volume] in Serum or Plasma
124
1141
3.24
2.34
42.9
13.4
umol/l
82.4
72.5
1.39
124
1141
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
13
4.78
2.30
1.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
50
345
1.73
2.29
5.7
3.0
ng/l
24.0
38.1
0.54
34
207
(3012516) Albumin [Mass/volume] in Urine
38
242
1.81
2.28
4.4
3.3
mg/l
2590.7
84.7
0.83
26
159
(3034770) Mitochondria Ab [Titer] in Serum
9
29
3.26
2.27
1.3
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
9
5.73
2.23
3.4
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
9
5.73
2.23
2.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
9
5.73
2.23
3.4
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
14
4.44
2.17
1.3
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
112
979
2.09
2.16
33.2
10.9
ml/min/173m2
83.7
86.7
0.59
97
777
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
37
2.85
2.16
3.6
5.6
%
1.2
1.4
—
10
37
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
25
3.34
2.13
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
83
2.21
2.12
8.1
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
38
2.77
2.06
1.3
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
38
2.77
2.06
1.3
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
32
2.94
2.04
1.0
5.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
11
4.68
1.96
2.8
5.3
%
72.6
67.1
—
5
11
(3024928) Oxygen saturation in Venous blood
6
16
3.88
1.96
2.5
4.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
9
34
2.77
1.90
3.9
5.9
%
0.6
0.7
—
9
34
(40768797) Stomach Pathology biopsy report
23
135
1.86
1.77
1.7
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
48
2.41
1.76
1.6
1.9
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
7
24
3.02
1.75
1.1
1.2
—
1.4
—
0
14
(3020682) Albumin/Creatinine [Ratio] in Urine
38
260
1.65
1.74
5.6
4.0
mg/mmol
66.5
11.7
1.19
27
163
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
13
3.95
1.73
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
31
2.68
1.69
2.1
2.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
19
3.26
1.68
4.8
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
19
3.26
1.68
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
21
124
1.83
1.59
1.7
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
15
3.42
1.54
7.0
4.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
21
2.94
1.52
5.2
2.5
kpa
8.5
8.8
—
6
21
(3013290) Carbon dioxide [Partial pressure] in Blood
6
21
2.94
1.52
5.3
2.5
kpa
4.7
4.9
—
6
21
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
37
2.54
1.51
1.2
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
9
39
2.40
1.46
13.7
8.7
%
1.2
1.2
—
9
39
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
9
39
2.40
1.46
13.7
8.6
%
0.7
0.7
—
9
39
(3000093) Morphology [Interpretation] in Blood Narrative
5
16
3.21
1.45
1.8
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
10
46
2.27
1.44
1.9
1.6
miu/ml
257.2
276.9
—
5
26
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
47
2.22
1.37
1.1
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
18
2.85
1.29
1.6
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
37
2.24
1.24
1.1
2.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
19
2.69
1.22
1.0
1.1
—
0.8
—
0
9
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
263
1.51
1.22
1.9
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
52
410
1.45
1.21
5.8
3.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
38
2.18
1.21
7.1
5.7
%
45.5
45.1
—
8
38
(3038515) Glucose [Moles/volume] in Venous blood
5
20
2.56
1.16
4.6
3.4
mmol/l
7.8
7.0
—
5
20
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
20
2.56
1.16
1.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
43
330
1.45
1.15
1.7
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
40
2.06
1.14
1.3
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
40
2.06
1.14
9.0
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
41
2.01
1.11
1.3
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
41
2.01
1.11
6.4
3.8
u/ml
11.1
3486.0
—
8
36
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
41
2.01
1.11
1.3
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
5
21
2.43
1.10
4.6
3.3
mmol/l
1.8
1.2
—
5
21
(3035637) Corticotropin [Mass/volume] in Plasma
5
21
2.43
1.10
1.0
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
99
1.70
1.06
2.2
2.0
—
—
—
0
0
(1002224) Polysomnography panel
10
53
1.96
1.04
1.1
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
104
947
1.51
1.03
6.8
5.2
mmol/mol
38.9
38.7
0.10
97
890
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
36
2.00
0.98
5.3
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
70
1.79
0.96
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
37
1.94
0.95
6.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
46
1.79
0.84
1.1
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
66
1.73
0.81
17.9
6.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
106
983
1.44
0.81
6.0
4.7
mu/l
1.9
1.9
0.09
100
906
(3000764) Benzodiazepines [Presence] in Urine
8
48
1.71
0.80
1.1
2.6
—
—
—
0
0
(4268621)
5
23
2.22
0.77
2.0
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
288
1.35
0.74
1.4
1.3
u/ml
1.5
0.8
0.32
12
76
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
85
1.59
0.72
4.8
3.1
ml/min/173m2
54.6
67.8
—
7
39
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
26
198
1.39
0.71
1.5
1.3
iu/ml
25.2
25.8
—
10
62
(3028707) Methadone [Presence] in Urine by Screen method
5
26
1.96
0.71
1.2
3.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
98
1045
0.74
0.68
4.8
4.1
mmol/l
1.4
1.5
0.91
90
971
(40761511) CBC panel - Blood by Automated count
120
1153
1.58
0.65
34.2
10.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
49
1.67
0.63
1.1
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
49
1.67
0.63
1.1
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
49
1.67
0.63
1.1
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
81
1.53
0.59
2.1
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
73
1.55
0.58
11.7
9.0
mmol/l
26.0
24.8
0.75
11
73
(21494755) Public health laboratory ask at order entry panel
16
116
1.43
0.58
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
106
1005
1.31
0.50
5.4
4.1
mmol/l
5.7
5.8
0.38
101
931
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
201
1.30
0.50
1.7
1.3
u/ml
1.1
8.2
—
10
79
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
69
1.49
0.46
1.2
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
78
1.45
0.45
1.5
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
68
1.35
0.38
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
108
1.33
0.37
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
84
1.34
0.31
6.9
3.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
139
1.26
0.31
1.8
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
73
1.25
0.26
6.2
3.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
76
1.20
0.25
4.0
2.4
—
—
—
0
0
(3019225) pH of Specimen
11
88
1.27
0.23
9.4
4.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
40
1.26
0.22
2.0
1.3
u/l
8.9
12.2
—
5
29
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
102
1050
0.86
0.22
4.7
4.2
mmol/l
4.6
4.7
0.31
96
985
(1761868) Lipid panel - Serum or Plasma
36
394
0.88
0.22
3.1
2.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4024509)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4027681)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
222
1.16
0.21
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
111
0.80
0.21
1.9
2.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
114
0.77
0.21
1.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
50
1.21
0.20
2.2
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
50
1.21
0.20
7.0
3.3
—
—
—
0
0
(3013512) EKG study
30
272
1.13
0.19
6.1
3.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5
68
0.72
0.17
2.8
2.2
ug/l
18.7
5.6
—
5
59
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
193
0.86
0.17
3.5
4.0
%
23.1
21.5
—
7
90
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
77
0.77
0.16
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
104
1061
0.90
0.13
5.2
4.5
mmol/l
2.7
2.8
0.21
93
986
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
98
1002
0.91
0.13
4.3
3.7
mmol/l
1.5
1.2
2.35
87
924
(3029937) Albumin [Presence] in Urine by Test strip
26
280
0.91
0.12
7.4
3.7
estimate
0.0
0.0
0.00
12
99
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
164
0.90
0.08
2.3
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
65
1.08
0.08
1.7
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
77
1.04
0.07
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
16
151
1.07
0.03
1.7
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
145
0.96
0.00
2.1
2.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
1.9
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
1.2
—
13.5
—
0
6
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
18.0
—
0
5
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
1.4
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
11.7
—
8.3
—
0
6
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
8
0.00
0.00
0.0
2.8
—
6.0
—
0
8
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEFNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFNAS | 3.678 [2.42, 5.58] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 387 females with D3_IMMUDEFNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFNAS | 2.774 [1.85, 4.16] | < 0.001 |
| Birth year | 0.986 [0.97, 1.0] | 0.025 |
During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 289 males with D3_IMMUDEFNAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEFNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.294% | 0.457% |
| 5 | 1.697% | 3.098% |
| 10 | 4.35% | 8.007% |
| 15 | 8.053% | 14.237% |
| 20 | 14.103% | 23.103% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEFNAS – Other or unspecified immunodeficiency
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data